PDCD1 and neoplasm: Interestingly, analysis of PD-1 expression on tumor-infiltrating CD8+ T cells revealed that in MEKi-treated tumors almost 40% of the infiltrating CD8+ T cells were PD-1lo, whereas in control tumors 85% of infiltrating CD8+ T cells expressed high levels of PD-1 (11).